Hematology

A groundbreaking study has revealed new insights into the molecular mechanisms that govern the activation and quiescence of haematopoietic stem and progenitor cells.

This nonrandomised study, conducted between 2017 and 2021, involved 201 patients across 43 centres, including both academic and community hospitals.

A study analysing data from the US Renal Data System has revealed a significant risk of pulmonary embolism in patients with end-stage kidney disease starting dialysis…

A new study accessed the Mayo Clinic database to investigate the long-term survival of patients with myeloproliferative neoplasms and acute myeloid leukaemia associated with multihit TP53 mutations…

Researchers have developed the ALA-CART platform to enhance CAR T cell therapy’s effectiveness against antigen-low leukemias.

A new study shows that GLP-1 receptor agonists (GLP-1RAs) could significantly reduce the risk of developing hematologic cancers in patients with Type 2 diabetes.

A study of 783 patients in 38 T cell therapy trials reveals reassuring results about the long-term safety of gene therapies for HIV-1 and cancer, with only 2.3% developing secondary malignancies.

Universal genetic testing for haemoglobinopathies can enhance early detection and health equity in newborn screening programmes worldwide.